Monsanto’s Roundup Cancer Label to be Added, After Appeal Rejected By Appeals Court

California is moving forward with new label warnings about glyphosate, the active ingredient linked to growing Roundup cancer concerns, after an Appeals Court rejected efforts by Monsanto to block the move. 

On June 26, the California Office of Environmental Health Hazard Assessment (OEHHA) announced that glyphosate would be added to its list of cancer-causing agents as of July 7.

As a result of the move, Monsanto will have to add a Roundup cancel label to all products sold in the state, alerting consumers that the popular herbicide is a probably carcinogenic. California’s OEHHA said it had been waiting for the outcome of attempts by Monsanto to appeal the move before adding the chemical to the list.


Were you or a loved one exposed to RoundUp?

Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin's Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated.

Learn More About this Lawsuit See If You Qualify For Compensation

A notice about the new label designation was posted by OEHHA in late March, indicating the intention to ad glyphosate to its Proposition 65 list of potential or known carcinogens. Monsanto called for an appeal and immediate stay in a June 16 petition in the U.S. District Court for the Northern District of California, but that petition was denied last week.

The cancer warnings for Roundup come after the World Health Organization’s International Agency for Research on Cancer (IARC) decided to classify glyphosate as a probably human carcinogen in mid-2015, and amid increasing concerns worldwide about the link between exposure to Roundup and non-Hodgkin’s lymphoma, as well as other cancers.

Last September, OEHHA indicated that it planned to list glyphosate as a cancer-causing agent. The listing will require new warnings on products sold in the state that contain glyphosate.

Following that decision, California regulators and Monsanto, the manufacturer of Roundup, waged a legal battle for months over whether the state can require Roundup to carry warnings that indicate that the weed killer may be carcinogenic.

“Monsanto’s challenge was unsuccessful in the trial court.  Although the case has been appealed, no stay of the listing has been granted,” the OEHHA stated in its announcement. “Therefore, glyphosate is being added to the Proposition 65 list on July 7, 2017.”

In the U.S., several hundred product liability lawsuits have been filed by farmers, landscapers, agricultural workers and others regularly exposed to Roundup, alleging that they may have avoided a diagnosis of non-Hodgkins lymphoma or other cancer if warnings had been provided by Monsanto.

Since October 2016, all federal Roundup lawsuits have been consolidated for pretrial proceedings as part of an MDL, or multidistrict litigation, which is centralized before U.S. District Judge Vince Chhabria in the Northern District of California. As part of the coordinated litigation, it is expected that a small group of bellwether trials will be prepared for early trial dates to help gauge how juries may respond to certain evidence and testimony that will be repeated throughout the cases. However, if Monsanto fails to reach Roundup settlements or another resolution for the failure to warn cases, hundreds of individual lawsuits may eventually be remanded back to the federal courts where they were originally filed for an separate trial dates.


Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

BioZorb Lawsuit Alleges Breast Tissue Marker Failed, Requiring Surgical Removal
BioZorb Lawsuit Alleges Breast Tissue Marker Failed, Requiring Surgical Removal (Posted yesterday)

A BioZorb lawsuit has been filed by several breast cancer survivors after the BioZorb implants moved out of place and failed to dissolve int he body, requiring surgical removal.

Fairness Hearing For Philips CPAP Recall Medical Monitoring Settlement Set for October
Fairness Hearing For Philips CPAP Recall Medical Monitoring Settlement Set for October (Posted yesterday)

A U.S. District Court judge has scheduled a fairness hearing for October in order to determine whether final approval should be granted to a $25 million Philips CPAP recall settlement agreement, which would pay former users $25 million to pay for future medical monitoring needs.

Abbott Laboratories Faces Jury Trial Over Claims Similac Caused NEC For Premature Infant
Abbott Laboratories Faces Jury Trial Over Claims Similac Caused NEC For Premature Infant (Posted 2 days ago)

Following a $60 million verdict in a similar lawsuit earlier this year, trial is underway involving claims brought by an Illinois mother, whose premature daughter developed NEC from Similac, alleging that Abbott failed to warn parents and medical staff of the devastating risks associated with the cow's milk-based formula.